Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/karger/the-role-of-ancillary-techniques-in-pulmonary-cytopathology-VaHmIZm2TY
References (64)
-
神津 吉基 (2011)
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma -
C. Powers (1998)
Diagnosis of Infectious Diseases: a Cytopathologist’s PerspectiveClinical Microbiology Reviews, 11
-
T. Vlajnic, S. Savic, A. Barascud, B. Baschiera, M. Bihl, B. Grilli, M. Herzog, J. Rebetez, L. Bubendorf (2018)
Detection of ROS1‐positive non‐small cell lung cancer on cytological specimens using immunocytochemistryCancer Cytopathology, 126
-
J. Andrici, Amy Sheen, L. Sioson, Kathryn Wardell, A. Clarkson, N. Watson, M. Ahadi, M. Farzin, C. Toon, A. Gill (2015)
Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytologyModern Pathology, 28
-
P. Pisapia, M. Lozano, E. Vigliar, Claudio Bellevicine, F. Pepe, U. Malapelle, G. Troncone (2017)
ALK and ROS1 testing on lung cancer cytologic samples: PerspectivesCancer Cytopathology, 125
-
RL Siegel, KD Miller, A Jemal (2018)
Cancer statistics, 2018, 68
-
P. Michelow, T. Omar, A. Field, C. Wright (2016)
The cytopathology of mycobacterial infectionDiagnostic Cytopathology, 44
-
A. Moreira, Adnan Hasanovic (2012)
Molecular Characterization by Immunocytochemistry of Lung Adenocarcinoma on Cytology SpecimensActa Cytologica, 56
-
Bryce Noll, Wei-Lien Wang, Y. Gong, Jun Zhao, N. Kalhor, V. Prieto, G. Staerkel, S. Roy-Chowdhuri (2018)
Programmed death ligand 1 testing in non–small cell lung carcinoma cytology cell block and aspirate smear preparationsCancer Cytopathology, 126
-
A. Kawahara, K. Azuma, A. Sumi, T. Taira, Kazutaka Nakashima, E. Aikawa, H. Abe, Tomohiko Yamaguchi, S. Takamori, J. Akiba, M. Kage (2011)
Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.Lung cancer, 74 1
-
S. Savic, B. Bode, J. Diebold, I. Tosoni, A. Barascud, B. Baschiera, B. Grilli, M. Herzog, E. Obermann, L. Bubendorf (2013)
Detection of ALK-Positive Non–Small-Cell Lung Cancers on Cytological Specimens: High Accuracy of Immunocytochemistry with the 5A4 CloneJournal of Thoracic Oncology, 8
-
W. Travis (2015)
WHO classification of tumours of the lung, pleura, thymus and heart -
(2013)
BAP 1 and cancer -
Eugen Minca, B. Portier, Zhen Wang, Christopher Lanigan, C. Farver, Yan Feng, P. Ma, Valeria Arrossi, N. Pennell, R. Tubbs (2013)
ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.The Journal of molecular diagnostics : JMD, 15 3
-
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
-
S. Tian, J. Killian, N. Rekhtman, R. Benayed, S. Middha, M. Ladanyi, O. Lin, M. Arcila (2016)
Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience.Archives of pathology & laboratory medicine
-
M. Mino‐Kenudson, L. Chirieac, Kenny Law, J. Hornick, N. Lindeman, E. Mark, David Cohen, B. Johnson, P. Jänne, A. Iafrate, S. Rodig (2010)
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard ImmunohistochemistryClinical Cancer Research, 16
-
D. Aisner, Dr. Rumery, D. Merrick, Dr. Kimi, L. Kondo, Dr. Nijmeh, Derek Linderman, R. Doebele, Ms. Thomas, Mr. Chesnut, -. MarileilaVarella, Garcia, Dr. Franklin, D. Camidge (2016)
Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience.Archives of pathology & laboratory medicine
-
S. Monaco, S. Dacic (2015)
Evaluation of Small Biopsy Material in Patients with Multiple and Secondary Tumors -
Yoshiki Kozu, K. Tsuta, T. Kohno, I. Sekine, A. Yoshida, Shun-ichi Watanabe, T. Tamura, J. Yokota, Kenji Suzuki, H. Asamura, K. Furuta, H. Tsuda (2011)
The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma.Lung cancer, 73 1
-
H. Wang, H. Wang, J. Agulnik, J. Agulnik, G. Kasymjanova, G. Kasymjanova, A. Wang, P. Jiménez, V. Cohen, Victor Cohen, D. Small, C. Pepe, L. Sakr, Pierre-Olivier Fiset, Manon Auger, S. Camilleri-Broët, M. Din, George Chong, L. Kempen, L. Kempen, A. Spatz (2018)
Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancerAnnals of Oncology, 29
-
A. Husain, T. Colby, N. Ordóñez, T. Allen, R. Attanoos, M. Beasley, K. Butnor, L. Chirieac, A. Churg, S. Dacic, F. Galateau-Salle, A. Gibbs, A. Gown, T. Krausz, L. Litzky, A. Marchevsky, A. Nicholson, V. Roggli, Anupama Sharma, W. Travis, A. Walts, M. Wick (2018)
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.Archives of pathology & laboratory medicine, 142 1
-
Haruhiko Nakamura, A. Mochizuki, T. Shinmyo, K. Ando, N. Kurimoto, K. Yokote, M. Takagi (2010)
Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.Anticancer research, 30 12
-
L. Tanoue (2012)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaYearbook of Pulmonary Disease, 2012
-
J. King, Nick Thatcher, C.A.C. Pickering, Philip Hasleton (2006)
Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reportsHistopathology, 49
-
(2003)
Homozygous deletion of CDKN 2 A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural me - sotheliomas -
Y. Yatabe, S. Dacic, A. Borczuk, A. Warth, P. Russell, S. Lantuejoul, M. Beasley, E. Thunnissen, G. Pelosi, N. Rekhtman, L. Bubendorf, M. Mino‐Kenudson, A. Yoshida, K. Geisinger, M. Noguchi, L. Chirieac, Johan Bolting, Jin-Haeng Chung, T. Chou, Gang Chen, C. Poleri, F. López-Rios, M. Papotti, L. Sholl, A. Roden, W. Travis, F. Hirsch, K. Kerr, M. Tsao, A. Nicholson, I. Wistuba, A. Moreira (2019)
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 14 3
-
A. Yoshida, K. Tsuta, S. Wakai, Y. Arai, H. Asamura, T. Shibata, K. Furuta, T. Kohno, R. Kushima (2014)
Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancersModern Pathology, 27
-
E. Thunnissen, A. Borczuk, D. Flieder, B. Witte, M. Beasley, Jin-Haeng Chung, S. Dacic, S. Lantuejoul, P. Russell, M. Bakker, J. Botling, E. Brambilla, E. Cuba, K. Geisinger, K. Hiroshima, A. Marchevsky, Y. Minami, A. Moreira, A. Nicholson, A. Yoshida, M. Tsao, A. Warth, E. Duhig, Gang Chen, Y. Matsuno, W. Travis, K. Butnor, W. Cooper, M. Mino‐Kenudson, N. Motoi, C. Poleri, G. Pelosi, K. Kerr, S. Aisner, Y. Ishikawa, R. Buettner, Naoto Keino, Y. Yatabe, M. Noguchi (2017)
The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of CasesJournal of Thoracic Oncology, 12
-
C. Selinger, Bob Li, N. Pavlakis, M. Links, A. Gill, Adrian Lee, S. Clarke, Thang Tran, T. Lum, P. Yip, L. Horvath, Bing Yu, M. Kohonen-Corish, S. O'toole, W. Cooper (2017)
Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare targetHistopathology, 70
-
E. Conde, A. Suárez-Gauthier, A. Benito, P. Garrido, R. García-Campelo, M. Biscuola, L. Paz-Ares, D. Hardisson, J. Castro, M. Camacho, D. Rodríguez-Abreu, I. Abdulkader, J. Ramírez, N. Reguart, M. Salido, L. Pijuan, E. Arriola, J. Sanz, V. Folgueras, N. Villanueva, J. Gómez-Román, M. Hidalgo, F. López-Rios (2014)
Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive ImmunohistochemistryPLoS ONE, 9
-
M. Lozano, J. Echeveste, M. Abengózar, L. Mejías, M. Idoate, A. Calvo, C. Andrea (2018)
Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.Archives of pathology & laboratory medicine, 142 3
-
L. Layfield, Lauren Pearson, B. Walker, S. White, R. Schmidt (2018)
Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Discrimination of Squamous Cell Carcinoma from Adenocarcinoma in Non-Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisActa Cytologica, 62
-
B. Skov, T. Skov (2017)
Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDxApplied Immunohistochemistry & Molecular Morphology, 25
-
A. Seo, T. Park, Yan-Ze Jin, P. Sun, Hyojin Kim, Hyun Chang, Jin-Haeng Chung (2014)
Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry.Lung cancer, 83 3
-
(2019)
Assess - ment of programmed death - ligand 1 ( PD - L 1 ) immunohistochemical expression on cytology specimens in non - small cell lung carcinoma -
S. Simonetti, M. Molina, C. Queralt, I. Aguirre, C. Mayo, J. Bertran-Alamillo, J. Sánchez, J. González-Larriba, U. Jiménez, D. Isla, T. Morán, S. Viteri, C. Camps, R. García-Campelo, B. Massutí, S. Benlloch, S. Cajal, M. Taron, R. Rosell (2010)
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancerJournal of Translational Medicine, 8
-
World Health Organization: Xpert MTB/RIF: WHO policy update and implementation manual -
G. Jiang, Chuifeng Fan, Xiupeng Zhang, Q. Dong, Liang Wang, Yang Liu, S. Dai, Lianhe Yang, Yong Zhang, Juanhan Yu, E. Wang (2013)
Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung CancerPLoS ONE, 8
-
EML 4 - ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound - guided transbronchial needle aspiration -
E. Thunnissen, T. Allen, J. Adam, D. Aisner, M. Beasley, A. Borczuk, P. Cagle, V. Capelozzi, W. Cooper, L. Hariri, I. Kern, S. Lantuejoul, R. Miller, M. Mino‐Kenudson, T. Radonic, Kirtee Raparia, N. Rekhtman, S. Roy-Chowdhuri, P. Russell, F. Schneider, L. Sholl, M. Tsao, M. Vivero, Y. Yatabe (2017)
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.Archives of pathology & laboratory medicine, 142 3
-
Y. Kato, N. Peled, M. Wynes, Koichi Yoshida, M. Pardo, C. Mascaux, T. Ohira, M. Tsuboi, J. Matsubayashi, T. Nagao, N. Ikeda, F. Hirsch (2010)
Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor MutationsJournal of Thoracic Oncology, 5
-
M. Tsao, K. Kerr, M. Kockx, M. Beasley, A. Borczuk, J. Botling, L. Bubendorf, L. Chirieac, Gang Chen, T. Chou, Jin-Haeng Chung, S. Dacic, S. Lantuejoul, M. Mino‐Kenudson, A. Moreira, A. Nicholson, M. Noguchi, G. Pelosi, C. Poleri, P. Russell, J. Sauter, E. Thunnissen, I. Wistuba, Hui Yu, M. Wynes, M. Pintilie, Y. Yatabe, F. Hirsch (2018)
PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 ProjectJournal of Thoracic Oncology, 13
-
N. Lindeman, P. Cagle, D. Aisner, M. Arcila, M. Beasley, E. Bernicker, Carol Colasacco, S. Dacic, F. Hirsch, K. Kerr, D. Kwiatkowski, M. Ladanyi, J. Nowak, L. Sholl, Robyn Temple-Smolkin, B. Solomon, L. Souter, E. Thunnissen, M. Tsao, Christina Ventura, M. Wynes, Y. Yatabe (2018)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyJournal of Thoracic Oncology, 13
-
A. Moreira (2015)
Role of Immunohistochemistry in the Detection of Targetable Mutations -
C. Selinger, Toni-Maree Rogers, P. Russell, S. O'toole, P. Yip, Gavin Wright, Z. Wainer, L. Horvath, M. Boyer, B. McCaughan, M. Kohonen-Corish, S. Fox, W. Cooper, B. Solomon (2013)
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationModern Pathology, 26
-
A. Churg, B. Sheffield, F. Galateau-Salle (2016)
New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?Archives of pathology & laboratory medicine, 140 4
-
S. Roy-Chowdhuri, D. Aisner, T. Allen, M. Beasley, A. Borczuk, P. Cagle, V. Capelozzi, S. Dacic, G. Santos, L. Hariri, K. Kerr, S. Lantuejoul, M. Mino‐Kenudson, A. Moreira, Kirtee Raparia, N. Rekhtman, L. Sholl, E. Thunnissen, M. Tsao, M. Vivero, Y. Yatabe (2016)
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.Archives of pathology & laboratory medicine
-
Masami Yoshida, Tadasuke Nagatomo, T. Ohnishi, M. Kawashima, A. Naitoh, E. Morii (2017)
Detection of epidermal growth factor receptor mutations in lung adenocarcinoma cytological specimens by immunocytochemistryMolecular and Clinical Oncology, 7
-
Adnan Hasanovic, D. Ang, A. Moreira, M. Zakowski (2012)
Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.Lung cancer, 77 2
-
Marta Cigognetti, S. Lonardi, S. Fisogni, P. Balzarini, V. Pellegrini, A. Tironi, L. Bercich, M. Bugatti, G. Rossi, B. Murer, M. Barbareschi, S. Giuliani, A. Cavazza, G. Marchetti, W. Vermi, F. Facchetti (2015)
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferationsModern Pathology, 28
-
Hyojin Kim, S. Yoo, J. Choe, J. Paik, Xianhua Xu, H. Nitta, Wenjun Zhang, T. Grogan, C. Lee, S. Jheon, Jin-Haeng Chung (2011)
Detection of ALK Gene Rearrangement in Non-small Cell Lung Cancer: A Comparison of Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization with Correlation of ALK Protein ExpressionJournal of Thoracic Oncology, 6
-
A. Hjerpe, V. Ascoli, C. Bedrossian, M. Boon, J. Creaney, B. Davidson, A. Dejmek, K. Dobra, A. Fassina, A. Field, P. Fırat, T. Kamei, Tadao Kobayashi, C. Michael, S. Önder, A. Segal, P. Vielh (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed‐type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of CytopathologyDiagnostic Cytopathology, 43
-
A. Kawahara, C. Yamamoto, Kazutaka Nakashima, K. Azuma, S. Hattori, Masaki Kashihara, H. Aizawa, Y. Basaki, M. Kuwano, M. Kage, T. Mitsudomi, M. Ono (2010)
Molecular Diagnosis of Activating EGFR Mutations in Non–Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical AnalysisClinical Cancer Research, 16
-
J. Gainor, A. Shaw (2013)
Novel targets in non-small cell lung cancer: ROS1 and RET fusions.The oncologist, 18 7
-
H. Hwang, B. Sheffield, S. Rodriguez, Kim Thompson, C. Tse, A. Gown, A. Churg (2016)
Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology SpecimensThe American Journal of Surgical Pathology, 40
-
A. Kawahara, C. Fukumitsu, T. Taira, H. Abe, Y. Takase, K. Murata, Tomohiko Yamaguchi, K. Azuma, H. Ishii, S. Takamori, J. Akiba, T. Hoshino, M. Kage (2015)
Epidermal growth factor receptor mutation status in cell‐free DNA supernatant of bronchial washings and brushingsCancer Cytopathology, 123
-
N. Takigawa, N. Ochi, H. Yamane (2018)
Histology versus cytology: PD-L1 testing in non-small cell lung cancer.Translational lung cancer research, 7 Suppl 3
-
(2014)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines -
Derek Allison, P. Simner, Syed Ali (2018)
Identification of infectious organisms in cytopathology: A review of ancillary diagnostic techniquesCancer Cytopathology, 126
-
A. Kitamura, W. Hosoda, E. Sasaki, T. Mitsudomi, Y. Yatabe (2010)
Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung CancerClinical Cancer Research, 16
-
M. Brevet, M. Arcila, M. Ladanyi (2010)
Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.The Journal of molecular diagnostics : JMD, 12 2
-
(2018)
IASLC Lung Cancer News: PD-L1 IHC Blueprint Project: ongoing progress toward consistency among assays -
A. Kawahara, C. Fukumitsu, Koichi Azuma, T. Taira, H. Abe, Y. Takase, K. Murata, E. Sadashima, Satoshi Hattori, Y. Naito, Jun Akiba (2018)
A Combined test using both cell sediment and supernatant cell‐free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patientsCytopathology, 29
- Publisher
- Karger
- Copyright
- © 2019 S. Karger AG, Basel
- ISSN
- 0001-5547
- eISSN
- 1938-2650
- DOI
- 10.1159/000498889
- Publisher site
- See Article on Publisher Site
Abstract
Ancillary techniques play an essential role in pulmonary cytopathology. Immunoperoxidase and special stains are by far the most common ancillary techniques used in cytopathology; however, the role of molecular diagnosis is growing, especially in the fields of pulmonary oncology and infectious disease. In this article, we review the uses of ancillary techniques in lung tumor diagnosis, lung tumor classification, predictive marker determination, primary versus metastasis differential diagnosis, and infectious organism detection.
Journal
Acta Cytologica – Karger
Published: Jan 1, 2020
Keywords: Ancillary testing; Pulmonary carcinomas; Lung; Cytopathology